Protease-Activated Drug Development

被引：185
作者：
Choi, Ki Young [1 ]
Swierczewska, Magdalena [1 ,2 ]
Lee, Seulki [1 ]
Chen, Xiaoyuan [1 ]
机构：
[1] NIBIB, LOMIN, NIH, Bethesda, MD 20892 USA
[2] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA
来源：
THERANOSTICS | 2012年 / 2卷 / 02期
基金：
美国国家卫生研究院;
关键词：
Protease; activatable probe; Alzheimer's disease; cancer; caspase; cathepsin; kallikrein; MMP; PSA; serine protease; aspartyl protease; PROSTATE-SPECIFIC ANTIGEN; ALBUMIN-BINDING PRODRUG; L-LEUCYL-DOXORUBICIN; SENSITIVE PHOTODYNAMIC AGENTS; COPOLYMER-BOUND ADRIAMYCIN; SQUAMOUS-CELL CARCINOMAS; TRANSGENIC MOUSE MODEL; BREAST-CANCER PATIENTS; HUMAN CATHEPSIN-B; MATRIX METALLOPROTEINASES;
D O I：
10.7150/thno.4068
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
In this extensive review, we elucidate the importance of proteases and their role in drug development in various diseases with an emphasis on cancer. First, key proteases are introduced along with their function in disease progression. Next, we link these proteases as targets for the development of prodrugs and provide clinical examples of protease-activatable prodrugs. Finally, we provide significant design considerations needed for the development of the next generation protease-targeted and protease-activatable prodrugs.
引用
收藏
页码：156 / 178
页数：23
相关论文
共 269 条
  • [91] Cysteine Cathepsins and the cutting edge of cancer invasion
    Gocheva, Vasilena
    Joyce, Johanna A.
    [J]. CELL CYCLE, 2007, 6 (01) : 60 - 64
  • [92] Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP)
    Graeser, Ralph
    Chung, Da-Eun
    Esser, Norbert
    Moor, Sandra
    Schaechtele, Christoph
    Unger, Clemens
    Kratz, Felix
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (05) : 1145 - 1154
  • [93] Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines
    Greco, Francesca
    Vicent, Maria J.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (13) : 1203 - 1213
  • [94] Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy
    Hamblin, MR
    Miller, JL
    Rizvi, I
    Loew, HG
    Hasan, T
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (05) : 937 - 943
  • [95] Hamblin MR, 2001, CANCER RES, V61, P7155
  • [96] Inhibition of interleukin 1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
    Hara, H
    Friedlander, RM
    Gagliardini, V
    Ayata, C
    Fink, K
    Huang, ZH
    ShimizuSasamata, M
    Yuan, JY
    Moskowitz, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 2007 - 2012
  • [97] Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
    Hartmann, A
    Hunot, S
    Michel, PP
    Muriel, MP
    Vyas, S
    Faucheux, BA
    Mouatt-Prigent, A
    Turmel, H
    Srinivasan, A
    Ruberg, M
    Evan, GI
    Agid, Y
    Hirsch, EC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2875 - 2880
  • [98] The biochemistry of apoptosis
    Hengartner, MO
    [J]. NATURE, 2000, 407 (6805) : 770 - 776
  • [99] Heppner KJ, 1996, AM J PATHOL, V149, P273
  • [100] URINARY KALLIKREIN EXCRETION IN ESSENTIAL AND MINERALOCORTICOID HYPERTENSION
    HOLLAND, OB
    CHUD, JM
    BRAUNSTEIN, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (02) : 347 - 356
567891011121314